BioMarin
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade BioMarin 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMRN
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307.
CEOAlexander Hardy
CEOAlexander Hardy
Employees3,040
Employees3,040
HeadquartersSan Rafael, California
HeadquartersSan Rafael, California
Founded1997
Founded1997
Employees3,040
Employees3,040
BMRN Key Statistics
Market cap12.96B
Market cap12.96B
Price-Earnings ratio32.03
Price-Earnings ratio32.03
Dividend yield—
Dividend yield—
Average volume1.61M
Average volume1.61M
High today$70.80
High today$70.80
Low today$67.85
Low today$67.85
Open price$70.20
Open price$70.20
Volume1.24M
Volume1.24M
52 Week high$94.85
52 Week high$94.85
52 Week low$60.63
52 Week low$60.63
BMRN News
Simply Wall St 2d
The Price Is Right For BioMarin Pharmaceutical Inc.BioMarin Pharmaceutical Inc.'s ( ) price-to-earnings (or "P/E") ratio of 31.9x might make it look like a strong sell right now compared to the market in the Uni...
Analyst ratings
81%
of 31 ratingsBuy
80.6%
Hold
19.4%
Sell
0%